Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Durect Corp (DRRX)

Durect Corp (DRRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Durect: Q2 Earnings Snapshot AP - Tue Aug 13, 3:08PM CDT

Durect: Q2 Earnings Snapshot

DRRX : 1.3700 (+1.48%)
Durect: Q1 Earnings Snapshot AP - Mon May 13, 3:17PM CDT

Durect: Q1 Earnings Snapshot

DRRX : 1.3700 (+1.48%)
Durect: Q4 Earnings Snapshot AP - Wed Mar 27, 3:19PM CDT

Durect: Q4 Earnings Snapshot

DRRX : 1.3700 (+1.48%)
Durect: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Durect: Q3 Earnings Snapshot

DRRX : 1.3700 (+1.48%)
DURECT Corporation Announces Presentations in Upcoming Investor Conferences PR Newswire - Thu Aug 31, 2023

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 1.3700 (+1.48%)
Durect: Q2 Earnings Snapshot AP - Wed Aug 9, 2023

Durect: Q2 Earnings Snapshot

DRRX : 1.3700 (+1.48%)
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate update....

DRRX : 1.3700 (+1.48%)
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update PR Newswire - Thu Aug 3, 2023

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 1.3700 (+1.48%)
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules PR Newswire - Thu Jul 20, 2023

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the...

DRRX : 1.3700 (+1.48%)
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis PR Newswire - Wed Jun 7, 2023

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company developing epigenetic therapies for the treatment of acute organ injuries and...

DRRX : 1.3700 (+1.48%)

Barchart Exclusives

2 EV Stocks to Sell Now, Despite the Fed's Big Rate Cut Barchart - 3 minutes ago
While the Fed's jumbo rate cut is a positive for the broader markets and the automotive sector, VinFast and Nikola are two EV stocks that still don't look like buys. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot